ESR1 and breast carcinoma: Testing the SERM activity of EPTA-Gd and TPTA-Gd was therefore performed in well-established ER responsive human breast cancer cell lines, MCF7 and T47D, in reference to the ER-negative MDA-MB-231 human breast cancer cells.